Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Deutsche Numis Keeps Their Hold Rating on CureVac (CVAC)
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Revance Therapeutics (RVNC) and CureVac (CVAC)
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates
CureVac Full Year 2023 Earnings: Misses Expectations
CureVac Full Year 2023 Earnings: Misses Expectations
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Q4 2023 CureVac NV Earnings Call Transcript
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
CureVac to cut costs in restructuring
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.